Physician profile
James Anderson
NPI 1851754154
$1,313.00
in general payments reported to CMS, 2019-2025
9 companies · $369 in 2025
The $369 reported for 2025 was more than what 81% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $98.35 · 2021: $33.25 · 2022: $105 · 2023: $22.44 · 2024: $371 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $568.69 | 2021-2025 | Gelsyn-3, Durolane |
| Depuy Synthes Sales INC. | $231.83 | 2022-2025 | Monovisc, Orthovisc |
| Merck Sharp & Dohme LLC | $203.10 | 2019-2020 | |
| Allergan, INC. | $125.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $98.78 | 2020-2024 | Euflexxa |
| Avanir Pharmaceuticals, INC. | $27.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.42 | 2019-2021 | |
| Polaris Technology Solutions LLC | $18.32 | 2024 | |
| Amgen INC. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.